CEREUnknown
Cerevel Therapeutics Holdings, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Cerevel Therapeutics Holdings, Inc. (CERE), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are CERE insiders buying or selling?
Cerevel Therapeutics Holdings, Inc. insiders reported 18 open-market buys ($799.8M) and 52 sells ($60.7M) across 70 Form 4 filings — a net buying position of $739.1M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 3, 2024)
Total Form 4 filings
70
SEC EDGAR
Insider filers
17
Insider buys (18)
$799.8M
Insider sells (52)
$60.7M
Insider sentiment
Net buyingNet insider flow of $739.1M in net buying.
Recent CERE insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 3, 2024 | Anthony N Coles | Director | Sale | 25.0K | $41.18 | $1.0M |
| Jun 5, 2024 | Anthony N Coles | Director | Sale | 50.0K | $40.61 | $2.0M |
| May 14, 2024 | Anthony N Coles | Director | Sale | 50.0K | $42.10 | $2.1M |
| Apr 3, 2024 | Anthony N Coles | Director | Sale | 50.0K | $42.33 | $2.1M |
| Mar 6, 2024 | Anthony N Coles | Director | Sale | 50.0K | $41.01 | $2.1M |
| Mar 4, 2024 | Anthony N Coles | Director | Sale | 50.0K | $41.16 | $2.1M |
| Feb 9, 2024 | John Renger | Chief Scientific Officer | Sale | 2.2K | $41.54 | $89.8K |
| Feb 9, 2024 | Anthony N Coles | Director | Sale | 2.5K | $41.54 | $104.1K |
| Jan 4, 2024 | Anthony N Coles | Director | Sale | 50.0K | $42.24 | $2.1M |
| Dec 28, 2023 | Ramiro Sanchez | Chief Medical Officer | Sale | 10.0K | $42.47 | $424.7K |
| Dec 27, 2023 | Kenneth Dipietro | Chief Human Resources Officer | Sale | 8.0K | $41.45 | $331.6K |
| Dec 22, 2023 | Ramiro Sanchez | Chief Medical Officer | Sale | 10.2K | $41.42 | $420.5K |
| Dec 22, 2023 | Kathleen Tregoning | Title: Chief Corporate Affairs Officer | Sale | 6.3K | $41.42 | $260.5K |
| Dec 19, 2023 | Ramiro Sanchez | Chief Medical Officer | Sale | 7.5K | $41.39 | $310.4K |
| Dec 11, 2023 | Ramiro Sanchez | Chief Medical Officer | Sale | 10.0K | $41.37 | $413.7K |
| Dec 8, 2023 | Scott Akamine | Chief Legal Officer | Sale | 17.5K | $38.64 | $676.2K |
| Nov 16, 2023 | Anthony N Coles | Director | Sale | 22.8K | $25.13 | $573.5K |
| Nov 9, 2023 | Anthony N Coles | Director | Sale | 27.2K | $25.02 | $680.1K |
| Nov 6, 2023 | Anthony N Coles | Director | Sale | 100.0K | $25.34 | $2.5M |
| Nov 3, 2023 | PATRICK DEVAL L | Director | Sale | 30.1K | $25.00 | $753.3K |
| Oct 18, 2023 | Christopher R Gordon | Director, 10% Owner | Purchase | 5.5M | $22.81 | $125.0M |
| Oct 18, 2023 | Adam Koppel | Director, 10% Owner | Purchase | 5.5M | $22.81 | $125.0M |
| Oct 18, 2023 | BAIN CAPITAL INVESTORS LLC | 10% Owner | Purchase | 5.5M | $22.81 | $125.0M |
| Oct 17, 2023 | Joseph Edelman | Director | Purchase | 876.8K | $22.81 | $20.0M |
| Sep 8, 2023 | Anthony N Coles | Director | Sale | 50.0K | $24.07 | $1.2M |
Showing the 25 most recent of 70 Form 4 filings for Cerevel Therapeutics Holdings, Inc..
Most active CERE insiders
- Anthony N Coles19 filings
- John Renger17 filings
- Joseph Edelman6 filings
- Abraham Ceesay4 filings
- Ramiro Sanchez4 filings
Ask anything about CERE insider activity
Use Trabud's AI agent to query Cerevel Therapeutics Holdings, Inc.'s Form 4 history in plain English — "Show me CERE CEO purchases this year" or compare it against any other ticker.
Open the AI agentCERE insider trading FAQ
Are Cerevel Therapeutics Holdings, Inc. insiders buying or selling?
Across 70 SEC Form 4 filings, Cerevel Therapeutics Holdings, Inc. (CERE) insiders reported 18 open-market purchases totaling $799.8M and 52 sales totaling $60.7M. That is a net buying position of $739.1M.
How many insiders trade CERE stock?
17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Cerevel Therapeutics Holdings, Inc.. The most recent filing was accepted on Jul 3, 2024.
Where does Trabud get CERE insider trading data?
All CERE insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.